ANI PHARMACEUTICALS INC (ANIP) Stock Income Statement
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 811.50M | 614.38M | 486.82M | 316.40M | 216.10M | |||
| Cost Of Goods | 323.25M | 250.21M | 181.51M | 138.80M | 100.60M | |||
| Gross Profit | 488.25M | 364.17M | 305.30M | 177.60M | 115.50M | |||
| Operating Expenses | 459.22M | 361.33M | 257.20M | 207.10M | 143.40M | |||
| Research and Development | 55.15M | 44.58M | 34.29M | 22.30M | 11.40M | |||
| Selling, General, and Administrative Expenses | 326.16M | 249.64M | 161.70M | 124.00M | 84.30M | |||
| Operating Income | 29.03M | 2.84M | 48.10M | -29.50M | -27.90M | |||
| Interest Income/Expense | -17.70M | -11.29M | -26.94M | -28.10M | -11.90M | |||
| Other Income/Expense | -3.83M | -4.03M | -159.00K | 700.00K | -4.30M | |||
| Non Recurring Items | -9.72M | -9.72M | -1.13M | -5.80M | -11.90M | |||
| Income Before Taxes | -2.23M | -22.21M | 19.87M | -62.70M | -56.10M | |||
| Income Tax | 616.00K | -3.69M | 1.09M | -14.80M | -13.50M | |||
| Net Income | -6.44M | -20.15M | 15.47M | -49.50M | -42.80M | |||
| EBITDA | 104.97M | 70.57M | 107.89M | 30.15M | 19.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.35 | -1.04 | 0.85 | -3.05 | -3.40 | |||
| Non GAAP EPS | 5.69 | 5.20 | 4.72 | 1.41 | 3.26 | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.17% | 59.27% | 62.71% | 56.13% | 53.45% | |||
| Profit Margin | -0.79% | -3.28% | 3.18% | -15.64% | -19.81% | |||
| Operating Profit Margin | 3.58% | 0.46% | 9.88% | -9.32% | -12.91% | |||
All data in USD